Notably, PD-L1 is a critical immune checkpoint protein that binds to programmed death 1 (PD-1) on T cells, leading to tumor immune escape and, consequently, increased immunosuppression, cancer aggressiveness, and drug resistance [8]. Here, CD274 is linked to cancer.